Early De-Risking and Optimization

Raymond Donninger, Ph.D.

Raymond has over 25 years’ experience in the pharmaceutical industry ranging from basic R&D to prescribing use of pharmaceuticals.  He has experience of working in the public and private sectors including small biotech and the service industry.  Over the past decade his focus has mainly been in the early development space and in helping to take molecules from a scientific concept to the clinic.  Raymond holds a Bachelor degree in Biochemistry and Microbiology, an Honours degree in Medical Biochemistry, a Medical degree and an MBA from Gordon Institute of Business Sciences.

Content by this expert

Recently published by Raymond

Podcast

Where There’s A Risk, There’s A Way: De-risking Drug Development at the Earliest Stages

Lonza’s wide array of analytical tools and professional experience create a go-to solution for small...

No DataSource has been set for this component or there is a component error.